Financial Accounting Quiz: Asset Impairment
20 questions · exam conditions
0:00
Asset ImpairmentQuestion 1 of 20

At December 31, a company performs an impairment test for a factory building under U.S. GAAP. The building has a carrying amount of $2,000,000. Management's best estimate of future undiscounted net cash flows is $1,900,000. A third-party appraiser provides a range for the building's fair value between $1,500,000 and $1,650,000, with no single value being more likely than another. What is the impairment loss to be recognized?

$100,000
$350,000
$425,000
$500,000
← Back to quizzes

Financial Accounting Quiz

Financial Accounting Quiz: Asset Impairment

Practice Asset Impairment in Financial Accounting with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Asset Impairment, giving you a quick way to practice the rules, question types, and explanations that matter most for Financial Accounting.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

At December 31, a company performs an impairment test for a factory building under U.S. GAAP. The building has a carrying amount of $2,000,000. Management's best estimate of future undiscounted net cash flows is $1,900,000. A third-party appraiser provides a range for the building's fair value between $1,500,000 and $1,650,000, with no single value being more likely than another. What is the impairment loss to be recognized?

  1. $100,000
  2. $350,000
  3. $425,000
  4. $500,000 (correct answer)
Explanation: First, the U.S. GAAP recoverability test (Step 1) indicates the asset is impaired because the carrying amount (2,000,000)exceedstheundiscountedfuturecashflows(2,000,000) exceeds the undiscounted future cash flows (1,900,000). Second, the impairment loss (Step 2) is the excess of the carrying amount over fair value. When fair value is expressed as a range and no amount within the range is a better estimate than any other, accounting standards (e.g., ASC 820) often require using the low end of the range for liability or loss measurement to be conservative. Therefore, fair value is deemed to be 1,500,000. The impairment loss is \(2,000,000 - $1,500,000 = $500,000).

Question 2

Delta Corp's manufacturing facility has a carrying amount of $2,400,000. Due to technological obsolescence, the facility's value in use is calculated as $1,950,000 based on discounted future cash flows. The facility could be sold for $2,100,000, but selling costs would amount to $150,000. Under IFRS, what amount should be used to measure any potential impairment loss?

  1. $1,950,000 because value in use is always the primary measurement basis under IFRS
  2. $2,100,000 because fair value represents the most objective market-based measurement
  3. $1,950,000 because it represents the higher of the two recoverable amount components
  4. $1,950,000 because fair value less costs of disposal is only $1,950,000 (correct answer)
Explanation: Under IFRS, recoverable amount is the higher of value in use and fair value less costs of disposal. Value in use = $1,950,000. Fair value less costs of disposal = $2,100,000 - $150,000 = $1,950,000. Since both amounts equal $1,950,000, the recoverable amount is $1,950,000. The impairment loss would be $2,400,000 - $1,950,000 = $450,000. Choice A is wrong because value in use is not always primary - we use the higher amount. Choice B ignores disposal costs. Choice C incorrectly states value in use is higher when both amounts are equal.

Question 3

A company owns a specialized machine with a carrying amount of $500,000. Due to the introduction of a more efficient technology, the machine's fair value has dropped to $350,000. However, management projects that the machine will still generate positive net cash inflows of $70,000 per year for its remaining 8-year useful life, after which it will have no residual value. Under U.S. GAAP, what is the amount of impairment loss the company should recognize?

  1. $0 (correct answer)
  2. $126,550
  3. $150,000
  4. $210,000
Explanation: Under U.S. GAAP, impairment of a long-lived asset held for use follows a two-step process. The first step is the recoverability test. The asset's carrying amount is compared to the sum of the undiscounted future net cash flows. Here, the carrying amount is 500,000. The undiscounted future cash flows are \(8 \text{ years} \times \70,000/\text{year} = $560,000). Since the carrying amount ($500,000) is less than the undiscounted future cash flows ($560,000), the asset is not considered impaired. No impairment loss is recognized. The second step of the test is not performed.

Question 4

A European company follows IFRS and is conducting an impairment review for a piece of equipment. The equipment has a carrying amount of €900,000. Management determines that the equipment could be sold for €750,000, but this would require incurring €30,000 in selling costs. Alternatively, continuing to use the equipment is expected to generate future net cash flows with a present value of €735,000. What is the impairment loss to be recognized under IFRS?

  1. €120,000
  2. €150,000
  3. €165,000 (correct answer)
  4. €180,000
Explanation: Under IFRS, an asset is impaired if its carrying amount exceeds its recoverable amount. The recoverable amount is the higher of fair value less costs to sell (FVLCTS) and value in use (VIU). In this case, FVLCTS is €750,000−€30,000=€720,000€750,000 - €30,000 = €720,000, and VIU is given as €735,000. The recoverable amount is the higher of these two, which is €735,000. The impairment loss is the excess of the carrying amount over the recoverable amount: €900,000−€735,000=€165,000€900,000 - €735,000 = €165,000.

Question 5

In Year 1, a U.S.-based company recognized a $100,000 impairment loss on a production line held for use. In Year 2, due to a significant and unexpected recovery in the market, the fair value of the production line increased substantially. In a parallel scenario, a German-based company following IFRS experienced an identical situation. Based on these facts, which of the following statements about the reversal of the impairment loss in Year 2 is correct?

  1. The U.S. company may reverse the loss, but the German company may not.
  2. The U.S. company may not reverse the loss, while the German company may reverse the loss up to a specified limit. (correct answer)
  3. Both companies may reverse the loss up to the asset's new fair value.
  4. Neither the U.S. company nor the German company may reverse the impairment loss.
Explanation: A key difference between U.S. GAAP and IFRS concerns the reversal of impairment losses. Under U.S. GAAP, an impairment loss recognized for an asset held for use cannot be reversed in a subsequent period, even if the asset's value recovers. Under IFRS, an impairment loss (other than for goodwill) can be reversed if there has been a change in the estimates used to determine the asset's recoverable amount. The reversal is limited, however; the new carrying amount cannot exceed what it would have been if the original impairment had not been recognized.

Question 6

A company operates a mining business with three primary long-lived assets at a single location: a highly specialized extraction machine, a standard-model conveyor system, and a processing plant. The extraction machine has no alternative use and its output is entirely dependent on the mine. The conveyor system could be sold separately but is integral to the current mining operation. The processing plant refines ore from the mine but also processes ore purchased from other companies. An impairment indicator affects the mining operation as a whole. For impairment testing purposes under either U.S. GAAP or IFRS, which is the most appropriate grouping of these assets?

  1. Each of the three assets must be tested for impairment individually because they are distinct physical items.
  2. The extraction machine and conveyor system should be grouped for testing, while the processing plant is tested separately. (correct answer)
  3. All three assets must be grouped together as a single unit because they are part of the same physical operation.
  4. Only the extraction machine should be tested, as its lack of alternative use makes it the most likely to be impaired.
Explanation: Assets should be tested for impairment at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets. This is known as an asset group (U.S. GAAP) or cash-generating unit (IFRS). The extraction machine and conveyor system are interdependent and generate cash flows as part of the mining operation. The processing plant, however, generates partially independent cash flows because it services outside parties. Therefore, the smallest identifiable group of largely independent cash flows consists of the machine and conveyor. The plant would be its own unit or part of a larger one.

Question 7

At year-end, Omega Corp. is testing a patent for impairment. The relevant data is as follows:

  • Carrying amount: $1,200,000
  • Remaining useful life: 5 years
  • Expected undiscounted future net cash flows: $220,000 per year
  • Fair value (determined by active market): $950,000
  • Present value of future net cash flows (6% discount rate): $926,780

Under U.S. GAAP, what is the impairment loss, if any, that Omega should recognize for the patent?

  1. $0
  2. $100,000
  3. $250,000 (correct answer)
  4. $273,220
Explanation: The U.S. GAAP impairment test for a finite-life intangible is a two-step process. Step 1 (Recoverability): Compare the carrying amount to the undiscounted future net cash flows. The total undiscounted cash flows are 5 \times \220,000 = $1,100,000.Sincethecarryingamount(. Since the carrying amount (1,200,000) is greater than the undiscounted cash flows (1,100,000), the patent is impaired. Step 2 (Loss Measurement): The impairment loss is the amount by which the carrying amount exceeds the asset's fair value. The loss is \(1,200,000 - $950,000 = $250,000). The present value of cash flows is irrelevant for the U.S. GAAP test but would be relevant under IFRS.

Question 8

A company decides to sell one of its business divisions. On the date the division's assets meet the criteria to be classified as held for sale, the assets have a carrying amount of $3,000,000. The company estimates the fair value of the assets to be $2,600,000 and anticipates incurring selling costs of $150,000 upon disposal. Immediately upon reclassification as held for sale, what amount of loss, if any, should the company recognize?

  1. $0
  2. $400,000
  3. $550,000 (correct answer)
  4. $150,000
Explanation: For assets classified as held for sale, an impairment loss is recognized if the carrying amount exceeds the fair value less costs to sell (FVLCTS). This is a one-step test. The carrying amount is 3,000,000. The FVLCTS is \(2,600,000 - $150,000 = $2,450,000). The required loss is the difference: (3,000,000 - \2,450,000 = $550,000). The asset group must be written down to its FVLCTS upon reclassification.

Question 9

A company determines that a machine is impaired under U.S. GAAP. The machine has an original cost of $500,000 and accumulated depreciation of $200,000 prior to impairment. The machine's fair value is $220,000. An impairment loss is calculated and recorded by increasing the accumulated depreciation account. After the impairment entry is posted, what are the balances for the machine's Accumulated Depreciation and its new carrying amount?

  1. Accumulated Depreciation: $200,000; Carrying Amount: $220,000
  2. Accumulated Depreciation: $280,000; Carrying Amount: $220,000 (correct answer)
  3. Accumulated Depreciation: $0; Carrying Amount: $220,000
  4. Accumulated Depreciation: $280,000; Carrying Amount: $300,000
Explanation: First, determine the pre-impairment carrying amount: (500,000 \text{ cost} - \200,000 \text{ AD} = $300,000). The impairment loss is the excess of the carrying amount over the fair value: (300,000 - \220,000 = $80,000). The journal entry debits Impairment Loss for $80,000 and credits Accumulated Depreciation for 80,000. The new balance in Accumulated Depreciation is \(200,000 + $80,000 = $280,000). The new carrying amount is the fair value, 220,000, which can be confirmed as \(500,000 \text{ cost} - $280,000 \text{ new AD} = $220,000).

Question 10

A company acquired a trademark for $4,000,000, which is considered to have an indefinite useful life. At the end of the current year, the company performs its annual impairment test. The fair value of the trademark is estimated to be $3,100,000. The company also projects that the trademark will generate undiscounted future cash flows of approximately $300,000 per year indefinitely. Under U.S. GAAP, what is the impairment loss?

  1. $0
  2. $900,000 (correct answer)
  3. The amount by which the carrying amount exceeds the present value of future cash flows.
  4. Cannot be determined without a discount rate.
Explanation: U.S. GAAP provides different impairment testing rules for indefinite-lived intangibles compared to finite-lived assets. The two-step recoverability test (comparing carrying value to undiscounted cash flows) is not used. Instead, a one-step test is applied where the carrying amount of the intangible asset is compared directly to its fair value. If the carrying amount exceeds the fair value, an impairment loss is recognized for the difference. Here, the carrying amount (4,000,000)exceedsthefairvalue(4,000,000) exceeds the fair value (3,100,000), so the impairment loss is (4,000,000 - \3,100,000 = $900,000). The undiscounted cash flows are irrelevant for this specific test.

Question 11

A company holds an asset that it intends to dispose of by abandonment. The asset has a carrying amount of $75,000 and is being depreciated. At the date the company commits to the abandonment plan, the asset's fair value is estimated to be $10,000, representing its salvage value. How should this asset be accounted for on the date the abandonment plan is finalized?

  1. The asset should be reclassified as held for sale and an impairment loss of $65,000 should be recognized.
  2. The asset should be written down to zero, with a loss of $75,000 recognized, as it will no longer be used.
  3. The asset should be reclassified as held for sale, and depreciation should cease, with no impairment loss recognized until disposal.
  4. The asset should be considered held and used until disposed of, and it should be tested for impairment under the standard held-for-use model. (correct answer)
Explanation: According to both U.S. GAAP and IFRS, an asset to be abandoned is not classified as held for sale because it will not be sold. Instead, it is considered held and used until its disposal. As such, it continues to be depreciated and is subject to the standard impairment test for assets held and used. A significant adverse change in the extent or manner an asset is used (i.e., a decision to abandon it) is a triggering event. The asset's carrying value ($75,000) would be compared to the undiscounted future cash flows (which would be just its salvage value of $10,000), triggering an impairment loss down to its fair value of $10,000. It is not reclassified as held for sale (A and C are incorrect), nor is it immediately written down to zero (D is incorrect).

Question 12

An impairment loss for a long-lived asset held for use has been recognized. Which of the following describes the most significant, direct impact of this impairment on the company's financial statements in the period following the impairment?

  1. The company's return on assets (ROA) will likely increase, assuming all other factors remain constant. (correct answer)
  2. The company's total cash flow from operating activities will decrease due to the non-cash impairment charge.
  3. The company will be required to switch from straight-line to an accelerated method of depreciation for the asset.
  4. The asset must be reclassified from non-current to current on the balance sheet.
Explanation: Recognizing an impairment loss reduces the carrying amount of the asset (the denominator in the ROA calculation, Net Income / Average Total Assets). It also reduces net income in the period of impairment, but in subsequent periods, the annual depreciation expense will be lower because it's based on the new, lower carrying amount. Lower depreciation leads to higher net income in those future periods. The combination of higher future net income and a lower asset base will lead to an increase in the calculated ROA, all else equal. An impairment charge is non-cash and does not directly affect cash flows (B). There is no requirement to change depreciation methods (C), and the asset remains non-current unless it meets held-for-sale criteria (D).

Question 13

A company is performing its annual impairment test under IFRS for a cash-generating unit (CGU) that includes goodwill. The carrying amounts are: PP&E, €600,000; Patent, €200,000; Goodwill, €100,000. The total carrying amount is €900,000. The recoverable amount of the CGU is determined to be €750,000. How should the €150,000 impairment loss be allocated among the assets?

  1. The loss is first allocated to reduce the carrying amount of goodwill to zero; any remaining loss is then allocated pro rata to the other assets. (correct answer)
  2. The loss is first allocated to the PP&E, as it is the most significant tangible asset in the CGU.
  3. The loss is allocated pro rata to all assets in the CGU based on their carrying amounts.
  4. The loss is first allocated to the patent, as intangible assets are considered most at risk of impairment.
Explanation: Under IFRS (IAS 36), when an impairment loss occurs for a CGU containing goodwill, the loss is allocated first to reduce the carrying amount of any goodwill assigned to the CGU. If the loss exceeds the goodwill, the remaining amount is allocated to the other assets in the CGU on a pro rata basis based on their carrying amounts. In this case, the total loss is €150,000. The first €100,000 of the loss reduces goodwill to zero. The remaining loss of €50,000 is allocated to the PP&E and the patent. (The pro rata allocation would be: Total other assets = €800k. PP&E gets (€600k/€800k) * €50k = €37,500. Patent gets (€200k/€800k) * €50k = €12,500.) The primary rule tested is that goodwill is written off first.

Question 14

A company is evaluating its primary manufacturing facility for impairment under U.S. GAAP. Which of the following events would most directly serve as a trigger indicating the need to perform an impairment test, as opposed to being a measurement used within the test itself?

  1. A third-party appraisal estimates that the facility's fair value has declined by 20% compared to the prior year.
  2. The company revises its cash flow projections, and the present value of the facility's future net cash flows is now below its carrying amount.
  3. A new environmental regulation is enacted that will require significant, previously unbudgeted capital expenditures to keep the facility compliant. (correct answer)
  4. The current net book value of the facility exceeds its estimated residual value at the end of its originally determined useful life.
Explanation: An impairment trigger is an event or change in circumstances indicating that a long-lived asset's carrying amount may not be recoverable. A new regulation requiring significant unplanned expenditure (C) is a classic example of an adverse change in the business or legal environment that acts as a trigger. A decline in fair value (A) and a change in the present value of cash flows (B) are measurements used within the impairment test (e.g., in Step 2 of the U.S. GAAP test or in the IFRS test), although the underlying reasons for these declines could also be triggers. An asset's book value exceeding its residual value (D) is the normal state for a depreciating asset and is not an impairment indicator.

Question 15

On January 1, Year 1, a company purchased equipment for $800,000. It had an estimated useful life of 10 years and no residual value, and was depreciated using the straight-line method. On December 31, Year 3, the company recognized a $120,000 impairment loss on the equipment and revised its remaining useful life to 5 years from that date. What is the amount of depreciation expense for this equipment in Year 4?

  1. $80,000
  2. $88,000 (correct answer)
  3. $104,000
  4. $112,000
Explanation: First, calculate the carrying amount at the time of impairment. Original annual depreciation was (800,000 / 10 = \80,000). After 3 years, accumulated depreciation was (80,000 \times 3 = \240,000), and the carrying amount was (800,000 - \240,000 = $560,000). After recognizing the 120,000 impairment loss, the new carrying amount (cost basis) is \(560,000 - $120,000 = $440,000). This new basis is then depreciated over the revised remaining useful life of 5 years. Depreciation expense for Year 4 is (440,000 / 5 = \88,000).

Question 16

On Jan 1, Y1, a company under IFRS acquired an asset for €200,000 with a 10-year life and no salvage value (straight-line depreciation). On Dec 31, Y2, the asset was impaired and written down to its recoverable amount of €120,000. On Dec 31, Y3, the asset's recoverable amount increased to €150,000 due to improved market conditions. What is the amount of the impairment reversal gain the company should recognize on December 31, Year 3?

  1. €20,000
  2. €35,000 (correct answer)
  3. €45,000
  4. €50,000
Explanation: This is a multi-step calculation. First, determine the asset's carrying amount at Dec 31, Y3 assuming no impairment occurred (the 'ceiling'). Original depreciation was €20,000/year (€200k/10). After 3 years, the carrying amount would have been €200,000−(3×€20,000)=€140,000€200,000 - (3 \times €20,000) = €140,000. Second, calculate the current carrying amount. After impairment on Dec 31, Y2, the basis was €120,000 with a remaining life of 8 years. Depreciation for Y3 was €120,000/8=€15,000€120,000 / 8 = €15,000. The carrying amount on Dec 31, Y3 is €120,000−€15,000=€105,000€120,000 - €15,000 = €105,000. Finally, the reversal is the amount to increase the carrying amount from €105,000 up to the lower of the new recoverable amount (€150,000) or the 'ceiling' (€140,000). The asset is written up to €140,000. The reversal gain is €140,000−€105,000=€35,000€140,000 - €105,000 = €35,000.

Question 17

An analyst is comparing the potential impairment of an asset group under both IFRS and U.S. GAAP using the following data:

  • Carrying Amount: $1,000,000
  • Sum of Undiscounted Future Cash Flows: $1,050,000
  • Fair Value: $800,000
  • Value in Use (PV of Future Cash Flows): $850,000
  • Costs to sell are negligible.

What is the impairment loss that should be recognized under IFRS and U.S. GAAP, respectively?

  1. IFRS: $150,000; U.S. GAAP: $200,000
  2. IFRS: $200,000; U.S. GAAP: $0
  3. IFRS: $150,000; U.S. GAAP: $0 (correct answer)
  4. IFRS: $0; U.S. GAAP: $0
Explanation: Under U.S. GAAP, the recoverability test compares the carrying amount (1,000,000)totheundiscountedfuturecashflows(1,000,000) to the undiscounted future cash flows (1,050,000). Since the carrying amount is less than the undiscounted cash flows, the asset is not impaired, and the loss is 0.UnderIFRS,thecarryingamount(0. Under IFRS, the carrying amount (1,000,000) is compared to the recoverable amount, which is the higher of fair value (800,000)andvalueinuse(800,000) and value in use (850,000). The recoverable amount is 850,000. Since the carrying amount exceeds the recoverable amount, an impairment loss is recognized for the difference: \(1,000,000 - $850,000 = $150,000).

Question 18

A company is testing an asset group for impairment under IFRS. The carrying amount of the asset group is €500,000. The group's value in use is calculated to be €420,000. Its fair value is estimated at €460,000. To sell the asset group, the company would incur legal fees of €15,000 and transportation costs of €10,000. What is the recoverable amount of the asset group?

  1. €420,000
  2. €460,000
  3. €445,000
  4. €435,000 (correct answer)
Explanation: Under IFRS, the recoverable amount is the higher of value in use (VIU) and fair value less costs to sell (FVLCTS). VIU is given as €420,000. FVLCTS is the fair value (€460,000) minus the direct costs of disposal. The costs to sell are the legal fees (€15,000) and transportation costs (€10,000), for a total of €25,000. Therefore, FVLCTS is €460,000−€25,000=€435,000€460,000 - €25,000 = €435,000. The recoverable amount is the higher of VIU (€420,000) and FVLCTS (€435,000), which is €435,000.

Question 19

Phoenix Industries purchased a patent for $600,000 with a legal life of 20 years and estimated useful life of 12 years. After 4 years of amortization, new competing technology emerged, reducing the patent's estimated remaining useful life to 3 years. The patent's current fair value is $280,000, and the present value of future cash flows from the patent is $320,000. What adjustments should Phoenix make in the current year?

  1. Record impairment loss of $80,000 and increase annual amortization to $106,667 going forward (correct answer)
  2. Record impairment loss of $80,000 and increase annual amortization to $80,000 going forward
  3. Increase annual amortization to $133,333 with no impairment loss required
  4. Record impairment loss of $120,000 and increase annual amortization to $66,667 going forward
Explanation: Current carrying amount = 600,000−(600,000 - (600,000 ÷ 12 × 4) = $400,000. The recoverable amount (value in use) is 320,000.Sincethecarryingamount(320,000. Since the carrying amount (400,000) exceeds the recoverable amount ($320,000), an impairment loss of $80,000 must be recorded. After impairment, the new carrying amount is $320,000, which must be amortized over the revised remaining useful life of 3 years = $320,000 ÷ 3 = $106,667 per year. Choice B uses incorrect amortization calculation. Choice C ignores the impairment requirement. Choice D uses wrong impairment amount.

Question 20

Northstar Corp. is testing its delivery fleet for impairment under US GAAP. The fleet has a carrying amount of $750,000 and is expected to generate undiscounted cash flows of $680,000 over its remaining useful life. The fleet's fair value is estimated at $620,000. Additionally, Northstar could avoid $180,000 in operating lease payments by selling the fleet and leasing equivalent vehicles instead. How should Northstar account for this situation?

  1. Recognize impairment loss of $130,000 based on carrying amount less fair value (correct answer)
  2. Recognize impairment loss of $50,000 based on the net benefit analysis including lease savings
  3. No impairment loss is required since the combined cash flows and lease savings exceed carrying amount
  4. Recognize impairment loss of $130,000 but also consider the lease arrangement as a separate transaction
Explanation: Under US GAAP, the impairment test compares carrying amount to undiscounted future cash flows from continued use of the asset in its current form. Since $750,000 (carrying amount) > $680,000 (undiscounted future cash flows), the asset is impaired. The impairment loss equals carrying amount minus fair value = $750,000 - $620,000 = $130,000. The lease savings from an alternative strategy are not included in the impairment test, as this evaluates the asset's value in its current use. Choice B incorrectly includes lease savings. Choice C misapplies the recoverability test. Choice D correctly identifies the impairment but unnecessarily complicates the accounting.